These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439 [No Abstract] [Full Text] [Related]
3. Treatments for COVID-19: where are we now? Mendes A Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900 [No Abstract] [Full Text] [Related]
4. World War against COVID-19: How strong is our armamentarium? Ramachandran V; Marimuthu RR; Chinnambedu RS Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555 [TBL] [Abstract][Full Text] [Related]
5. Plea for multitargeted interventions for severe COVID-19. Gaborit BJ; Bergmann JF; Mussini C; Arribas JR; Behrens G; Walmsley S; Pozniak A; Raffi F Lancet Infect Dis; 2020 Oct; 20(10):1122-1123. PubMed ID: 32325035 [No Abstract] [Full Text] [Related]
6. Oxytocin as a potential defence against Covid-19? Soumier A; Sirigu A Med Hypotheses; 2020 Jul; 140():109785. PubMed ID: 32344303 [No Abstract] [Full Text] [Related]
7. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? Severa M; Farina C; Salvetti M; Coccia EM Front Immunol; 2020; 11():1459. PubMed ID: 32655578 [No Abstract] [Full Text] [Related]
8. Puzzle of highly pathogenic human coronaviruses (2019-nCoV). Li J; Liu W Protein Cell; 2020 Apr; 11(4):235-238. PubMed ID: 32088858 [No Abstract] [Full Text] [Related]
9. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy. Stringer KA; Puskarich MA; Kenes MT; Dickson RP Pharmacotherapy; 2020 May; 40(5):382-386. PubMed ID: 32267979 [No Abstract] [Full Text] [Related]
10. Purposing Saikosaponins for the treatment of COVID-19. Bahbah EI; Negida A; Nabet MS Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743 [No Abstract] [Full Text] [Related]
11. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents. Ayaz S; Crea F Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654 [No Abstract] [Full Text] [Related]
13. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? Sargin G; Yavaşoğlu Sİ; Yavasoglu I Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306 [No Abstract] [Full Text] [Related]
15. Statins in coronavirus outbreak: It's time for experimental and clinical studies. Bifulco M; Gazzerro P Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478 [No Abstract] [Full Text] [Related]
17. Is the type of diabetes treatment relevant to outcome of COVID-19? Bloomgarden Z J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193 [No Abstract] [Full Text] [Related]
18. Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia. Tiscornia JE; Poggio TV; Feinsilber DG; Coleman AE Skinmed; 2020; 18(4):254-255. PubMed ID: 33050993 [No Abstract] [Full Text] [Related]
19. Lithium for the 2019 novel coronavirus. Gómez-Bernal G Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073 [No Abstract] [Full Text] [Related]
20. Investigating hypothiocyanite against SARS-CoV-2. Cegolon L Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009 [No Abstract] [Full Text] [Related] [Next] [New Search]